泡泡玛特港股盘中一度暴跌9%，为逾一个月最大跌幅，股价承压之际，做空力量持续集聚。据标普全球数据，截至上周四，泡泡玛特的卖空 股份已升至流通股的6.3%，创2023年8月以来最高水平。分析预计，泡泡玛特本季度美国销售增速将放缓至500%以下，此前预测增长 1200%。 光大证券国际策略师Kenny Ng表示，投资者对泡泡玛特销售势头放缓存在担忧，同时卖方的一些谨慎观点也打压了股价。 从增长1200%降至不足500%？美国销售增速或大幅放缓 美国市场表现成为焦点，此前泡泡玛特在三季度财报中披露美国销售同比增长超1200%，令投资者对海外扩张充满期待。 但最新迹象显示增长动能正在减弱。伯恩斯坦驻香港亚洲消费股分析师Melinda Hu指出，股价疲软"很可能是受11月份北美线下销售趋势下 滑推动"，她预计公司本季度美国销售增速将放缓至500%以下。 晨星分析师Jeff Zhang警告，潜在的美国销售疲软可能削弱市场对泡泡玛特增长的信心，海外销售势头此前一直是投资者紧密追踪的关键指 标。 泡泡玛特股价周一遭遇重挫，投资者对这家潮玩制造商在美国市场的增长势头产生疑虑。在公司此前公布美国市场超预期增长后，市场正密 切关注 ...

美国市场表现成为焦点，此前泡泡玛特在三季度财报中披露美国销售同比增长超1200%，令投资者对海 外扩张充满期待。 但最新迹象显示增长动能正在减弱。伯恩斯坦驻香港亚洲消费股分析师Melinda Hu指出，股价疲软"很 可能是受11月份北美线下销售趋势下滑推动"，她预计公司本季度美国销售增速将放缓至500%以下。 晨星分析师Jeff Zhang警告，潜在的美国销售疲软可能削弱市场对泡泡玛特增长的信心，海外销售势头 此前一直是投资者紧密追踪的关键指标。 泡泡玛特股价周一遭遇重挫，投资者对这家潮玩制造商在美国市场的增长势头产生疑虑。在公司此前公 布美国市场超预期增长后，市场正密切关注其销售动能能否维持。 周一，泡泡玛特港股盘中一度暴跌9%，为逾一个月最大跌幅，较8月高点累计回撤约40%。市场担忧其 在美国"黑五"促销期间的销售可能未达预期，打击了投资者信心。 股价承压之际，做空力量持续集聚。据标普全球数据，截至上周四，泡泡玛特的卖空股份已升至流通股 的6.3%，创2023年8月以来最高水平。 光大证券国际策略师Kenny Ng表示，投资者对泡泡玛特销售势头放缓存在担忧，同时卖方的一些谨慎 观点也打压了股价。 从增长1 ...

以下文章来源于天灏资本 ，作者天灏资本 天灏资本 . 天灏资本专注以下服务：1）企业估值战略：使它们以有利的估值融资或上市；2） 企业金融战略：以 资本家的思维帮助企业将资产变成造福机；3）现金及债务管理战略。 天灏资本同时提高服务给资产管 理公司，作为他们的投资顾问及研究团队。 导语：这是中国消费股历史上最跌宕起伏、最戏剧性的翻盘剧本之一。 2025年11月2日，厦门的一场普通政府活动上，瑞幸咖啡CEO郭瑾一轻描淡写地说了一句话，却 瞬间引爆了整个中概股圈："我们正在积极推进重返美国主板上市的事宜。" 五年零五个月前，瑞幸还被视为华尔街最大的笑话。 2020年4月2日，自曝22亿元财务造假，股 价从高点51美元暴跌至1.38美元，创始人被永久市场禁入，市值蒸发逾九成，最终被纳斯达克毫 不留情地踢出局，沦落至OTC粉单市场。 而今，瑞幸在中国坐拥超过 2.6万家门店，稳居咖啡连锁龙头，最新市值117亿美元，股价回升 至36.4美元，较最低点暴涨26倍。 现在，这家公司正试图带着曾经的 "污点记录"，再次叩响纳斯达克的大门。这是中国消费股历史 上最跌宕起伏、最戏剧性的翻盘剧本之一。 过去五年，瑞幸的经历更像是一 ...

Summary of Meituan's Earnings Call Company Overview - **Company**: Meituan (3690.HK) - **Industry**: Food delivery and local services in China Key Points Financial Performance and Forecasts - Meituan's Q4 2025 earnings forecast has been reduced by 31% due to declining profitability in its in-store business [1][12] - Revenue estimates for 2025 and 2026 have been adjusted downwards by 2% and 5% respectively, reflecting the impact of intensified competition on revenue and profits [16] - Adjusted earnings per share (EPS) for 2025 is now projected at -3.11 CNY, down from -2.59 CNY, indicating a 20% decrease [16] - The target price for Meituan is set at 95 HKD, based on a 15x multiple of the expected 2027 earnings [20][19] Competitive Landscape - Meituan maintains a leading position in the mid-to-high price order market for food delivery, but faces increasing competition from Alibaba, which is gradually capturing high-value consumer segments [2][12] - The competition is expected to intensify, particularly with Alibaba enhancing its 88VIP membership benefits, indicating that the battle for high-value users will be crucial in the Chinese food delivery and local services market [2][12] Business Segments - **Food Delivery**: The worst period is believed to be over, with management noting improvements in unit economics due to a better competitive landscape. However, price competition is expected to ease gradually [5][12] - **In-store Business**: The core local business saw a year-on-year decline in operating profit of 29 billion CNY, attributed to increased competition from Alibaba and Douyin [6][12] - **New Ventures**: Meituan's international food delivery brand "Keeta" has expanded into Qatar, Kuwait, Dubai, and Brazil, which is expected to increase losses in the short term but shows long-term potential [5][12] Risks and Uncertainties - Significant uncertainties exist regarding the sustainability of profitability in the in-store business, the intensity and duration of subsidy wars in food delivery, and the capital intensity and return cycles of overseas investments [1][12][19] - Downside risks include a weaker-than-expected consumer environment and slower-than-expected narrowing of losses in community group buying [21][19] Market Performance - Meituan's stock has underperformed, with a year-to-date decline of 32.4% and a 12-month decline of 40.5% [9][12] - The stock's valuation upside is considered limited until clearer evidence of improved profitability and rational competition emerges [12][19] Conclusion - The overall outlook for Meituan remains cautious, with a "Neutral" rating maintained until more predictable profit trends and rational competition in the core food delivery business are observed [12][19]

IT之家 11 月 28 日消息，美团今日发布截至 2025 年 9 月 30 日的第三季度业绩公告： | | 未經審核 | | | | | | --- | --- | --- | --- | --- | --- | | | 截至下列日期止三個月 | | | | | | | 2025年9月30日 | | 2024年9月30日 | | | | | | 佔收入 | | 佔收入 | | | | 金額 | 自分比 | 金額 | 百分比 | 同比筹動 | | | (人民幣千元,百分比除外) | | | | | | 收入 | 95,488,113 | 100.0% | 93,577,319 | 100.0% | 2.0% | | 經營(虧損)/ 溢利 | (19,759,350) | (20.7%) | 13.685.176 | 14.6% | 不摘用 | | 期内(虧損)／溢利 | (18,632,088) | (19.5%) | 12,864,954 | 13.7% | 不শ用 | | 非國際財務報告會計準則計量!: | | | | | | | 經調整EBITDA | (14,841,897) | (15.5%) | ...

Core Insights - BYD Company Limited is expanding its presence in Europe to mitigate domestic market pressures and compete with Tesla and NIO in the electric vehicle sector [1] - The company is set to release its quarterly earnings on November 26, 2025, with expectations of an earnings per share of $0.20 and revenue of $38.5 billion, driven by increased new-car registrations in Europe [2][6] - The launch of the ATTO 2 DM-i Super Hybrid in Barcelona is a key part of BYD's strategy to provide electrified mobility solutions in Europe, featuring a range of up to 90 kilometers on electric power alone and a total range of 1,000 kilometers with a petrol engine [3][6] Financial Metrics - BYD aims to sell up to 1.6 million vehicles internationally by 2026, reflecting a commitment to overseas expansion and expectations of high double-digit growth starting in 2025 [4] - The company's financial metrics include a P/E ratio of 36.20 and a price-to-sales ratio of 0.92, indicating strong investor confidence in its growth potential [4][6] - Despite a low debt-to-equity ratio of 0.13, BYD's current ratio of 0.76 suggests challenges in covering short-term liabilities, while an enterprise value to sales ratio of 0.83 and an earnings yield of 2.76% highlight its strong market position [5][6]

Core Insights - Celsius stock has experienced a significant decline of 58% from its peak in March 2024, despite a remarkable 7,330% increase over the previous five years [1][2] Financial Performance - In Q3 2023, Celsius reported a year-over-year revenue growth of 173%, reaching $725 million, largely due to the acquisition of Alani Nu [3] - The Celsius brand itself achieved a sales growth of 44% in the same quarter [3] Market Dynamics - The stock's decline may be attributed to slower revenue growth compared to previous years, with a 25-fold increase from 2018 to 2023, and a notable slowdown in scanner growth at just 13% [4] - There are concerns about potential inventory accumulation despite the revenue increase [4] Growth Opportunities - Celsius has significant potential for international expansion, as international revenue currently represents a small portion of total sales [5] - Analysts project a compound annual revenue growth rate of 21% for Celsius from 2025 to 2027 [5] Competitive Landscape - Celsius faces strong competition from established brands like Monster Beverage and Red Bull, which have greater brand recognition and loyalty [8] - The lack of a strong economic moat raises concerns about Celsius's long-term growth potential [8][9]

Investment Rating - The report assigns an "Outperform" rating to Gushengtang, expecting a relative return exceeding 10% over the next 12-18 months [16]. Core Insights - Gushengtang announced the acquisition of 100% equity in Singapore's Da Zhong Tang, which operates 14 TCM clinics, aiming to enhance its market share and expand its business network in Singapore [5][6]. - The acquisition is anticipated to positively impact the company's performance in 2026, leveraging Da Zhong Tang's established brand and operational presence in key commercial areas of Singapore [6][7]. - The company plans to continue its overseas expansion through a combination of mergers and acquisitions, partnerships, and self-established clinics, targeting the addition of 10-20 new stores in Singapore and around 20 clinics in Hong Kong by 2026 [7][8]. Summary by Sections Acquisition Details - Gushengtang's acquisition of Da Zhong Tang will consolidate its financial results into the group's statements, enhancing its operational scale in Singapore [5][6]. Market Expansion Strategy - The company aims to expand its presence in Singapore through a mix of M&A, partnerships, and new clinic establishments, with a goal of generating significant overseas revenue by 2026 [7]. Operational Enhancements - Gushengtang plans to utilize its domestic supply chain for Chinese herbal products to support its overseas clinics, while enhancing internal treatment capabilities through AI technology and expert training [8].

Core Viewpoint - The completion of the acquisition of 100% equity in Singapore's Dazhongtang marks a significant step for the company towards large-scale overseas expansion, with plans to increase the number of clinics in Singapore and enter markets like Hong Kong and Malaysia [1][2]. Group 1: Acquisition and Expansion Plans - The company has acquired 14 traditional Chinese medicine clinics in Singapore, covering key business districts and residential areas [2]. - The revenue of Dazhongtang in 2024 was approximately 8 million Singapore dollars (around 50 million RMB), with a growth rate exceeding 5% in 2025 [2]. - The company aims to acquire an additional 10-20 clinics in Singapore and become the leading TCM service brand in the region by 2026 [2]. Group 2: Domestic Market and Policy Environment - The domestic policy environment is stabilizing, which is favorable for leading companies in the industry [2]. - In Wuxi, the company's store revenue increased by over 40% year-on-year in October 2025, with a profit margin of 26%, significantly above the company average [2]. - The optimization of traditional Chinese medicine decoction pieces procurement rules allows the company to enjoy favorable pricing without participating in collective procurement [2]. Group 3: Shareholder Returns and Financial Outlook - The company has repurchased shares worth 232 million HKD from July 1 to November 17, 2025, significantly exceeding the 85 million HKD repurchase in the first half of the year [3]. - The management has committed to maintaining a 50% dividend payout ratio, reflecting confidence in the company's growth [3]. - The adjusted revenue growth forecasts for 2025E, 2026E, and 2027E are 11.3%, 21.9%, and 24.0%, respectively, with adjusted net profit growth of 11.9%, 23.8%, and 26.3% [3].

Core Viewpoint - Luckin Coffee has reported a strong Q3 revenue of 15.287 billion RMB, signaling its intent to return to the US main board after overcoming past financial scandals [1][2][6]. Financial Performance - Total net revenue for Q3 reached 15.287 billion RMB, a year-on-year increase of 50.2% [2]. - The number of global stores has grown to 29,214, with a net addition of 3,008 stores in the quarter [2]. - Monthly active customers surpassed 112 million, marking a 40.6% increase year-on-year, with over 42 million new customers [2]. - GAAP operating profit was 1.777 billion RMB, a 12.9% increase, but the operating margin fell from 15.5% to 11.6% [2]. - Net profit decreased by 1.9% to 1.28 billion RMB [2]. Cost Structure - The increase in revenue was offset by rising delivery costs, which reached 2.889 billion RMB, a 211.4% increase due to a surge in orders from third-party delivery platforms [3]. Strategic Layout - The company emphasizes self-pickup as its core strategy, with delivery serving as a supplementary option [4]. - High-density store networks are a competitive advantage, allowing for lower rental and labor costs while maintaining profitability with a pricing strategy of 9.9 RMB [4]. - Internationally, Luckin has opened 29 new overseas stores, bringing the total to 118, with a focus on Singapore and the US [5]. Return to US Market - The company is actively pursuing a return to the US main board, with plans being discussed but no definitive timeline established [6][7]. - The return is seen as a significant event, potentially enhancing liquidity and valuation by 10% to 25% for Chinese companies transitioning from OTC to the main board [8]. Future Outlook - The CEO expressed caution regarding Q4 and next year's performance due to high international coffee bean prices and reduced delivery subsidies [9]. - The company aims to focus on long-term development, enhancing product and brand innovation while leveraging digital operations to meet diverse customer needs [9].